Brokerages Set Ventas, Inc. (NYSE:VTR) Price Target at $79.31

Ventas, Inc. (NYSE:VTR) has received an average recommendation of “Moderate Buy” from the eighteen brokerages that are currently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $79.3125.

Several research firms have recently commented on VTR. Citigroup upped their price target on shares of Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a research report on Tuesday, November 11th. Wells Fargo & Company upped their target price on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Evercore ISI increased their price target on shares of Ventas from $77.00 to $80.00 and gave the stock an “outperform” rating in a research report on Monday, September 15th. Jefferies Financial Group reiterated a “buy” rating and set a $93.00 price target on shares of Ventas in a research note on Monday, December 15th. Finally, Cantor Fitzgerald boosted their price objective on shares of Ventas from $77.00 to $85.00 and gave the company an “overweight” rating in a research report on Friday, October 31st.

Insiders Place Their Bets

In related news, CFO Robert F. Probst sold 33,591 shares of the stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $76.77, for a total value of $2,578,781.07. Following the completion of the sale, the chief financial officer directly owned 168,364 shares of the company’s stock, valued at approximately $12,925,304.28. This represents a 16.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Debra A. Cafaro sold 41,294 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $79.01, for a total transaction of $3,262,638.94. Following the sale, the chief executive officer owned 1,145,695 shares in the company, valued at approximately $90,521,361.95. The trade was a 3.48% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 688,184 shares of company stock worth $50,726,248 over the last quarter. 0.80% of the stock is currently owned by corporate insiders.

Institutional Trading of Ventas

Hedge funds and other institutional investors have recently modified their holdings of the company. Norges Bank purchased a new position in shares of Ventas during the 2nd quarter valued at $344,740,000. Vanguard Group Inc. raised its holdings in Ventas by 4.1% during the second quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock valued at $4,533,937,000 after acquiring an additional 2,854,751 shares during the period. UBS Group AG lifted its position in shares of Ventas by 142.4% in the third quarter. UBS Group AG now owns 3,507,841 shares of the real estate investment trust’s stock valued at $245,514,000 after acquiring an additional 2,060,770 shares in the last quarter. Citigroup Inc. boosted its stake in shares of Ventas by 451.9% in the second quarter. Citigroup Inc. now owns 2,316,344 shares of the real estate investment trust’s stock worth $146,277,000 after acquiring an additional 1,896,627 shares during the period. Finally, Lasalle Investment Management Securities LLC grew its position in shares of Ventas by 1,135.1% during the third quarter. Lasalle Investment Management Securities LLC now owns 1,552,880 shares of the real estate investment trust’s stock worth $108,686,000 after purchasing an additional 1,427,151 shares in the last quarter. 94.18% of the stock is owned by hedge funds and other institutional investors.

Ventas Price Performance

NYSE VTR opened at $79.13 on Thursday. The stock has a market capitalization of $37.17 billion, a price-to-earnings ratio of 152.18, a PEG ratio of 1.99 and a beta of 0.78. Ventas has a 1-year low of $56.68 and a 1-year high of $81.89. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.32 and a quick ratio of 0.32. The business’s fifty day moving average price is $76.06 and its 200-day moving average price is $69.84.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Wednesday, October 29th. The real estate investment trust reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.01. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The company had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.44 billion. During the same quarter in the prior year, the business earned $0.80 earnings per share. Ventas’s revenue for the quarter was up 20.5% compared to the same quarter last year. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. On average, equities analysts predict that Ventas will post 3.4 earnings per share for the current year.

Ventas Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st will be issued a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Wednesday, December 31st. Ventas’s payout ratio is currently 369.23%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.